Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major

Mayra E Lorenzo1, Jae U Jung, Hidde L Ploegh

  • 1Department of Pathology, Harvard Medical School, Boston Massachusetts 02115, USA.

Insights

Human herpesvirus 8 (HHV8) K3 protein targets major histocompatibility complex (MHC) class I for degradation. This process involves the ubiquitin-proteasome system and protease activity within endosomes, leading to MHC class I downregulation.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Human herpesvirus 8 (HHV8) evades the immune system by downregulating MHC class I complexes.
  • HHV8 K3 and K5 proteins, with PHD domains similar to E3 ubiquitin ligases, mediate this downregulation.

Purpose of the Study:

  • To investigate the role of the ubiquitin-proteasome system in HHV8 K3-mediated MHC class I downregulation.
  • To elucidate the endocytic pathway and proteolytic mechanisms involved.

Main Methods:

  • Utilized proteasome and protease inhibitors in HHV8 K3-expressing cells.
  • Analyzed the trafficking and degradation of MHC class I complexes within the endocytic pathway.

Main Results:

  • Proteasome and protease inhibitors stabilized MHC class I complexes.
  • Proteasome inhibition altered MHC class I sorting, preventing delivery to a dense endosomal compartment.
  • MHC class I complexes undergo sequential cleavage by cysteine and aspartyl proteases in endosomes, yielding soluble fragments.

Conclusions:

  • HHV8 K3 directs MHC class I internalization and targets them for degradation via a ubiquitin-proteasome-dependent pathway.
  • The process involves specific endosomal compartments and sequential proteolytic cleavage.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.